Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2025: USD 793.01 M

Zydus Lifesciences Limited Operating Cash Flow is USD 793.01 M for the year ending March 31, 2025, a 104.92% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2024 was USD 386.99 M, a 18.29% change year over year.
  • Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2023 was USD 327.15 M, a 18.06% change year over year.
  • Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2022 was USD 277.11 M, a -38.38% change year over year.
  • Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2021 was USD 449.73 M, a 35.27% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities